The event got going with speaker Gwilym Thompson, Health Economics Lead at Janssen discussing ‘Health Economics in the real-world setting’. This pre-conference workshop provided insight into ‘real-world’ health economics, i.e. not the ‘hard-core’ discipline of healthcare modelling based on randomised controlled trials, but the use of front-line evidence to assess the value of a new treatment in terms of patients, the NHS and broader society. When looking for real-world evidence, the researcher must think carefully about what question/questions to ask.
Amanda Pulfer, Joint Managing Director of pH Associates (an OPEN Health company) a business specialising in real world evidence, spoke during the ‘Utilising Real World Data in Oncology’ session. Topics covered, specifically focussing on oncology, included:
- What is real world data?
- Why is real world data important to the NHS?
- How do you collect real world data?
- How is real world data used?
Continuing to look toward future changes in care, attendees also heard about a variety of interesting clinical updates from experts in the field, on such subjects as Myeloma, ‘what’s new in pancreas cancer?’ and side effects in immunotherapy.
The Annual Symposium would not be complete without the Succinct lecture ‒ an inspirational talk from outside of the clinical world, offering important messages for oncology pharmacists. In addition to enhancing clinical knowledge and skills, BOPA also provides an opportunity for broader personal development which this year came in the form of speak Jim Lawless’s ‘Taming Tigers’ talk. The tigers in Jim’s talk are not striped felines. They are the self-imposed barriers that stop us from achieving (or even attempting) some of the goals that face us throughout our lives.